Cardiac imaging procedures and the COVID-19 pandemic: recommendations of the European Society of Cardiovascular Radiology (ESCR)

Int J Cardiovasc Imaging. 2020 Oct;36(10):1801-1810. doi: 10.1007/s10554-020-01892-8. Epub 2020 May 26.

Abstract

The severe acute respiratory syndrome coronavirus 2019 (SARS-CoV-2) pandemic currently constitutes a significant burden on worldwide health care systems, with important implications on many levels, including radiology departments. Given the established fundamental role of cardiovascular imaging in modern healthcare, and the specific value of cardiopulmonary radiology in COVID-19 patients, departmental organisation and imaging programs need to be restructured during the pandemic in order to provide access to modern cardiovascular services to both infected and non-infected patients while ensuring safety for healthcare professionals. The uninterrupted availability of cardiovascular radiology services remains, particularly during the current pandemic outbreak, crucial for the initial evaluation and further follow-up of patients with suspected or known cardiovascular diseases in order to avoid unnecessary complications. Suspected or established COVID-19 patients may also have concomitant cardiovascular symptoms and require further imaging investigations. This statement by the European Society of Cardiovascular Radiology (ESCR) provides information on measures for safety of healthcare professionals and recommendations for cardiovascular imaging during the pandemic in both non-infected and COVID-19 patients.

Keywords: COVID-19; Cardiac magnetic resonance; Cardiovascular computed tomography; SARS-Cov-2; Safety.

Publication types

  • Review

MeSH terms

  • Betacoronavirus*
  • COVID-19
  • Cardiac Imaging Techniques / methods*
  • Cardiovascular Diseases / diagnostic imaging*
  • Coronavirus Infections / prevention & control*
  • Disinfection
  • Europe
  • Humans
  • Pandemics / prevention & control*
  • Patient Safety
  • Personal Protective Equipment
  • Pneumonia, Viral / prevention & control*
  • SARS-CoV-2
  • Societies, Medical